SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-012553
Filing Date
2023-04-17
Accepted
2023-04-17 16:35:47
Documents
63
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1632585
2 ex31-1.htm EX-31.1 12410
3 ex32-1.htm EX-32.1 5677
4 form10-k_001.jpg GRAPHIC 13553
5 form10-k_002.jpg GRAPHIC 17258
  Complete submission text file 0001493152-23-012553.txt   7441761

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE endv-20221231.xsd EX-101.SCH 48627
7 XBRL CALCULATION FILE endv-20221231_cal.xml EX-101.CAL 44950
8 XBRL DEFINITION FILE endv-20221231_def.xml EX-101.DEF 245413
9 XBRL LABEL FILE endv-20221231_lab.xml EX-101.LAB 412378
10 XBRL PRESENTATION FILE endv-20221231_pre.xml EX-101.PRE 323974
57 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1376130
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Filer) CIK: 0001528172 (see all company filings)

IRS No.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55453 | Film No.: 23824383
SIC: 3845 Electromedical & Electrotherapeutic Apparatus